Literature DB >> 21515431

Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects.

Fabio Di Domenico1, Rukhsana Sultana, Eugenio Barone, Marzia Perluigi, Chiara Cini, Cesare Mancuso, Jian Cai, William M Pierce, D Allan Butterfield.   

Abstract

Phosphorylation on tyrosine, threonine and serine residues represents one of the most important post-translational modifications and is a key regulator of cellular signaling of multiple biological processes that require a strict control by protein kinases and protein phosphatases. Abnormal protein phosphorylation has been associated with several human diseases including Alzheimer's disease (AD). One of the characteristic hallmarks of AD is the presence of neurofibrillary tangles, composed of microtubule-associated, abnormally hyperphosphorylated tau protein. However, several others proteins showed altered phosphorylation levels in AD suggesting that deregulated phosphorylation may contribute to AD pathogenesis. Phosphoproteomics has recently gained attention as a valuable approach to analyze protein phosphorylation, both in a quantitative and a qualitative way. We used the fluorescent phosphospecific Pro-Q Diamond dye to identify proteins that showed alterations in their overall phosphorylation in the hippocampus of AD vs. control (CTR) subjects. Significant changes were found for 17 proteins involved in crucial neuronal process such as energy metabolism or signal transduction. These phosphoproteome data may provide new clues to better understand molecular pathways that are deregulated in the pathogenesis and progression of AD.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21515431      PMCID: PMC3119855          DOI: 10.1016/j.jprot.2011.03.033

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  108 in total

1.  The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase, in different brain regions in Alzheimer's disease.

Authors:  M Y Aksenov; H M Tucker; P Nair; M V Aksenova; D A Butterfield; S Estus; W R Markesbery
Journal:  Neurochem Res       Date:  1999-06       Impact factor: 3.996

2.  Large-scale proteomics analysis of the human kinome.

Authors:  Felix S Oppermann; Florian Gnad; Jesper V Olsen; Renate Hornberger; Zoltán Greff; György Kéri; Matthias Mann; Henrik Daub
Journal:  Mol Cell Proteomics       Date:  2009-04-15       Impact factor: 5.911

Review 3.  The phosphoproteomics data explosion.

Authors:  Simone Lemeer; Albert J R Heck
Journal:  Curr Opin Chem Biol       Date:  2009-07-19       Impact factor: 8.822

4.  Phosphorylation of thr(668) in the cytoplasmic domain of the Alzheimer's disease amyloid precursor protein by stress-activated protein kinase 1b (Jun N-terminal kinase-3).

Authors:  C L Standen; J Brownlees; A J Grierson; S Kesavapany; K F Lau; D M McLoughlin; C C Miller
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

5.  Protein-protein interactions between the testis brain RNA-binding protein and the transitional endoplasmic reticulum ATPase, a cytoskeletal gamma actin and Trax in male germ cells and the brain.

Authors:  X Q Wu; S Lefrancois; C R Morales; N B Hecht
Journal:  Biochemistry       Date:  1999-08-31       Impact factor: 3.162

6.  Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

Authors:  Alessandra Castegna; Michael Aksenov; Marina Aksenova; Visith Thongboonkerd; Jon B Klein; William M Pierce; Rosemarie Booze; William R Markesbery; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2002-08-15       Impact factor: 7.376

Review 7.  New age of neuroproteomics in Alzheimer's disease research.

Authors:  Branislav Kovacech; Norbert Zilka; Michal Novak
Journal:  Cell Mol Neurobiol       Date:  2009-02-19       Impact factor: 5.046

8.  Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A.

Authors:  C X Gong; I Grundke-Iqbal; K Iqbal
Journal:  Neuroscience       Date:  1994-08       Impact factor: 3.590

9.  Identification of tyrosine phosphoproteins in signaling pathway triggered TGF-a by using functional proteomics technology.

Authors:  Lin Ruan; Guo-Liang Wang; Yan Chen; Hong Yi; Can-E Tang; Peng-Fei Zhang; Mao-Yu Li; Cui Li; Fang Peng; Jian-Ling Li; Zhu-Chu Chen; Zhi-Qiang Xiao
Journal:  Med Oncol       Date:  2010-01-05       Impact factor: 3.064

Review 10.  Glial fibrillary acidic protein: dynamic property and regulation by phosphorylation.

Authors:  M Inagaki; Y Nakamura; M Takeda; T Nishimura; N Inagaki
Journal:  Brain Pathol       Date:  1994-07       Impact factor: 6.508

View more
  40 in total

1.  An investigation of the molecular mechanisms engaged before and after the development of Alzheimer disease neuropathology in Down syndrome: a proteomics approach.

Authors:  Giovanna Cenini; Ada Fiorini; Rukhsana Sultana; Marzia Perluigi; Jian Cai; Jon B Klein; Elizabeth Head; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2014-08-20       Impact factor: 7.376

2.  Longitudinal study of differential protein expression in an Alzheimer's mouse model lacking inducible nitric oxide synthase.

Authors:  Michael D Hoos; Brenna M Richardson; Matthew W Foster; Angela Everhart; J Will Thompson; M Arthur Moseley; Carol A Colton
Journal:  J Proteome Res       Date:  2013-09-18       Impact factor: 4.466

3.  Immobilization of a Ce(IV)-substituted polyoxometalate on ethylenediamine-functionalized graphene oxide for selective extraction of phosphoproteins.

Authors:  Meng-Meng Wang; Shuai Chen; Dan-Dan Zhang; Yong-Liang Yu; Jian-Hua Wang
Journal:  Mikrochim Acta       Date:  2018-11-19       Impact factor: 5.833

4.  Collapsin response mediator protein-2 phosphorylation promotes the reversible retraction of oligodendrocyte processes in response to non-lethal oxidative stress.

Authors:  Agata Fernández-Gamba; María Celeste Leal; Chera L Maarouf; Christiane Richter-Landsberg; Terence Wu; Laura Morelli; Alex E Roher; Eduardo M Castaño
Journal:  J Neurochem       Date:  2012-04-27       Impact factor: 5.372

5.  Hippocampal Proteomic Analysis Reveals Distinct Pathway Deregulation Profiles at Early and Late Stages in a Rat Model of Alzheimer's-Like Amyloid Pathology.

Authors:  Sonia Do Carmo; Gogce Crynen; Tiffany Paradis; Jon Reed; M Florencia Iulita; Adriana Ducatenzeiler; Fiona Crawford; A Claudio Cuello
Journal:  Mol Neurobiol       Date:  2017-05-13       Impact factor: 5.590

Review 6.  Recent advances in quantitative neuroproteomics.

Authors:  George E Craft; Anshu Chen; Angus C Nairn
Journal:  Methods       Date:  2013-04-25       Impact factor: 3.608

Review 7.  Integrative biological analysis for neuropsychopharmacology.

Authors:  Mark R Emmett; Roger A Kroes; Joseph R Moskal; Charles A Conrad; Waldemar Priebe; Fernanda Laezza; Anke Meyer-Baese; Carol L Nilsson
Journal:  Neuropsychopharmacology       Date:  2013-06-26       Impact factor: 7.853

Review 8.  Extracellular matrix proteomics in schizophrenia and Alzheimer's disease.

Authors:  Manveen K Sethi; Joseph Zaia
Journal:  Anal Bioanal Chem       Date:  2016-09-06       Impact factor: 4.142

Review 9.  New insight into neurodegeneration: the role of proteomics.

Authors:  Ramavati Pal; Guido Alves; Jan Petter Larsen; Simon Geir Møller
Journal:  Mol Neurobiol       Date:  2013-12-10       Impact factor: 5.590

Review 10.  Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?

Authors:  Guillermo Moya-Alvarado; Noga Gershoni-Emek; Eran Perlson; Francisca C Bronfman
Journal:  Mol Cell Proteomics       Date:  2015-12-11       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.